These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27483129)

  • 1. Pharmacokinetic Studies of Sustained-Release Depot of Dexamethasone in Beagle Dogs.
    Blizzard C; Desai A; Driscoll A
    J Ocul Pharmacol Ther; 2016 Nov; 32(9):595-600. PubMed ID: 27483129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity and Pharmacokinetics of Sustained-Release Dexamethasone in Beagle Dogs.
    Driscoll A; Blizzard C
    Adv Ther; 2016 Jan; 33(1):58-67. PubMed ID: 26733409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension.
    Scoper SV; Kabat AG; Owen GR; Stroman DW; Kabra BP; Faulkner R; Kulshreshtha AK; Rusk C; Bell B; Jamison T; Bernal-Perez LF; Brooks AC; Nguyen VA
    Adv Ther; 2008 Feb; 25(2):77-88. PubMed ID: 18309465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of γ-cyclodextrin nanoparticle suspension eye drops in tear fluid.
    Jóhannesson G; Moya-Ortega MD; Ásgrímsdóttir GM; Lund SH; Thorsteinsdóttir M; Loftsson T; Stefánsson E
    Acta Ophthalmol; 2014 Sep; 92(6):550-6. PubMed ID: 24373641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.
    Papangkorn K; Higuchi JW; Brar B; Higuchi WI
    J Ocul Pharmacol Ther; 2018 May; 34(4):325-334. PubMed ID: 29432054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model.
    Torkildsen G; Abelson MB; Gomes PJ; McLaurin E; Potts SL; Mah FS
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):79-90. PubMed ID: 28072552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate.
    Gao Y; Sun Y; Ren F; Gao S
    Drug Dev Ind Pharm; 2010 Oct; 36(10):1131-8. PubMed ID: 20334543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.
    Wang C; Hou H; Nan K; Sailor MJ; Freeman WR; Cheng L
    Exp Eye Res; 2014 Dec; 129():74-82. PubMed ID: 25446320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.
    Le Merdy M; Fan J; Bolger MB; Lukacova V; Spires J; Tsakalozou E; Patel V; Xu L; Stewart S; Chockalingam A; Narayanasamy S; Rouse R; Matta M; Babiskin A; Kozak D; Choi S; Zhang L; Lionberger R; Zhao L
    AAPS J; 2019 May; 21(4):65. PubMed ID: 31111305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged exposure to loteprednol etabonate in human tear fluid and rabbit ocular tissues following topical ocular administration of Lotemax gel, 0.5%.
    Glogowski S; Lowe E; Siou-Mermet R; Ong T; Richardson M
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):66-73. PubMed ID: 24325539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis.
    Sebbag L; Yan Y; Smith JS; Allbaugh RA; Wulf LW; Mochel JP
    J Ocul Pharmacol Ther; 2019; 35(6):341-349. PubMed ID: 31070497
    [No Abstract]   [Full Text] [Related]  

  • 12. Prednisolone and dexamethasone are systemically absorbed after topical application of ophthalmic suspensions in healthy dogs.
    Ewald MM; Rankin AJ; Meekins JM; Magnin G; KuKanich B
    Am J Vet Res; 2022 Jan; 83(4):339-348. PubMed ID: 35038305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes.
    Chang-Lin JE; Burke JA; Peng Q; Lin T; Orilla WC; Ghosn CR; Zhang KM; Kuppermann BD; Robinson MR; Whitcup SM; Welty DF
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4605-9. PubMed ID: 21421864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems.
    Lee SB; Geroski DH; Prausnitz MR; Edelhauser HF
    Exp Eye Res; 2004 Mar; 78(3):599-607. PubMed ID: 15106940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model.
    Xu J; Wang Y; Li Y; Yang X; Zhang P; Hou H; Shi Y; Song C
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):527-40. PubMed ID: 18001232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
    Daull P; Paterson CA; Kuppermann BD; Garrigue JS
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults.
    Blizzard C; McLaurin EB; Driscoll A; Silva FQ; Vantipalli S; Metzinger JL; Goldstein MH
    Clin Ophthalmol; 2021; 15():2055-2061. PubMed ID: 34040341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
    Walters T; Rinehart M; Krebs W; Holdbrook M
    Cornea; 2010 Mar; 29(3):263-8. PubMed ID: 20098307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the African green monkey as a preclinical model for ocular pharmacokinetic studies.
    Glogowski S; Ward KW; Lawrence MS; Goody RJ; Proksch JW
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):290-8. PubMed ID: 22235843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of topically applied ciprofloxacin in tears of mesocephalic and brachycephalic dogs.
    Hendrix DV; Cox SK
    Vet Ophthalmol; 2008; 11(1):7-10. PubMed ID: 18190345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.